Search

everythinglearnresearchcommunity

for

Search:↓

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

New suturing technique with wider intervals and shallow stitches helps prevent scalp scars and promotes hair growth.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Dr. Shoji Okuda's pioneering work on hair transplantation was overlooked and could have significantly advanced the field if recognized sooner.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

Finasteride can cause rare breast growth side effect, with varying recovery after stopping.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.